NHS FDP rollout failure quantified for the first time: 16 trusts and health boards explicitly not using it
Weak uptake of the NHS Federated Data Platform (FDP) in the UK has moved from Burnham's stated political intent on 17 Oct to replace it to quantifiable evidence on 18 Oct.
Read more
The Guardian, based on first-hand replies to freedom of information (FOI) requests, shows that 16 NHS trusts and health boards have explicitly not used the £330 million FDP since its introduction in Mar 2024. Their reasons for rejecting it are specific and negative: duplicated functions, a step backwards, no significant improvement, and being overtaken by other systems. The timing coincides with a 'crunch decision' for the Burnham government on the break clause in the seven-year contract, and the FOI data will be used as ammunition on doubts about effectiveness, raising the probability of an early exit. But the £330 million multi-year contract is a limited exposure within Palantir's overall business. This is a regional tail risk rather than something that changes the overall thesis.
Key evidence
- Guardian, 17 Oct, based on first-hand FOI replies: more than two dozen replies from NHS trusts and health boards in England show that 16 have explicitly not used the £330 million FDP since it was introduced in Mar 2024
- University Hospitals of North Midlands: it offered no functions beyond those of existing systems
- Dorset: it will not go live with it
- Greater Manchester Integrated Care Board: the Palantir system is duplicative and 'retrograde'
- A Suffolk trust: other systems have surpassed the FDP's functions
- A Cambridgeshire trust uses it but sees no significant improvement over its local systems
Show 3 more
- Some organisations gave positive feedback (better waiting list management and surgery scheduling)
- The timing is key: it coincides with the Burnham government facing a crunch decision on the break clause in the seven-year contract
- The FDP is a multi-year government contract, and its £330 million ceiling is a very small share of Palantir's overall business
Catalysts to watch
- Q3 results on 2 Nov: EMEA revenue and the wording on RPO
- Whether the break clause in the seven-year contract is triggered
- Further political moves by the Burnham government based on the FOI data
- Disclosure of more NHS trust FOI replies
Risks
- FOI evidence that speeds up triggering of the break clause would lead to early termination of the contract
- The negative demonstration effect of a flagship UK case could spill over to other European government customers
- A worsening regulatory and political narrative could weigh on new EMEA signings
- But 16 trusts not using it does not mean the contract ends. NHS trusts choose for themselves whether to use it, so some non-adoption is structural
- Poor word of mouth on the rollout does not itself show up in the Q3 numbers
Sources (2)
- Guardian, 17 Oct: based on first-hand FOI replies, 16 NHS trusts and health boards explicitly do not use the FDP
- Trusts and health boards cited: University Hospitals of North Midlands, Dorset, Greater Manchester Integrated Care Board, a Suffolk trust and a Cambridgeshire trust
A brief is a lead for our research, not a verified conclusion or advice.